161 related articles for article (PubMed ID: 35725896)
21. Genotoxicity of 1,3-butadiene and its epoxy intermediates.
Walker VE; Walker DM; Meng Q; McDonald JD; Scott BR; Seilkop SK; Claffey DJ; Upton PB; Powley MW; Swenberg JA; Henderson RF;
Res Rep Health Eff Inst; 2009 Aug; (144):3-79. PubMed ID: 20017413
[TBL] [Abstract][Full Text] [Related]
22. APOBEC-induced mutations and their cancer effect size in head and neck squamous cell carcinoma.
Cannataro VL; Gaffney SG; Sasaki T; Issaeva N; Grewal NKS; Grandis JR; Yarbrough WG; Burtness B; Anderson KS; Townsend JP
Oncogene; 2019 May; 38(18):3475-3487. PubMed ID: 30647454
[TBL] [Abstract][Full Text] [Related]
23. Clonality analysis of cervical cancer on microdissected archival materials by PCR-based X-chromosome inactivation approach.
Guo Z; Thunberg U; Sallstrom J; Wilander E; Ponten J
Int J Oncol; 1998 Jun; 12(6):1327-32. PubMed ID: 9592194
[TBL] [Abstract][Full Text] [Related]
24. Clinical impact of clonal and subclonal TP53, SF3B1, BIRC3, NOTCH1, and ATM mutations in chronic lymphocytic leukemia.
Nadeu F; Delgado J; Royo C; Baumann T; Stankovic T; Pinyol M; Jares P; Navarro A; Martín-García D; Beà S; Salaverria I; Oldreive C; Aymerich M; Suárez-Cisneros H; Rozman M; Villamor N; Colomer D; López-Guillermo A; González M; Alcoceba M; Terol MJ; Colado E; Puente XS; López-Otín C; Enjuanes A; Campo E
Blood; 2016 Apr; 127(17):2122-30. PubMed ID: 26837699
[TBL] [Abstract][Full Text] [Related]
25. Accumulation of somatic mutations in proliferating T cell clones from children treated for leukemia.
Finette BA; Homans AC; Rivers J; Messier T; Albertini RJ
Leukemia; 2001 Dec; 15(12):1898-905. PubMed ID: 11753611
[TBL] [Abstract][Full Text] [Related]
26. Somatic Host Cell Alterations in HPV Carcinogenesis.
Litwin TR; Clarke MA; Dean M; Wentzensen N
Viruses; 2017 Aug; 9(8):. PubMed ID: 28771191
[TBL] [Abstract][Full Text] [Related]
27. The mutational landscape of early- and typical-onset oral tongue squamous cell carcinoma.
Campbell BR; Chen Z; Faden DL; Agrawal N; Li RJ; Hanna GJ; Iyer NG; Boot A; Rozen SG; Vettore AL; Panda B; Krishnan NM; Pickering CR; Myers JN; Guo X; Lang Kuhs KA
Cancer; 2021 Feb; 127(4):544-553. PubMed ID: 33146897
[TBL] [Abstract][Full Text] [Related]
28. Cytogenetic analysis of tumor clonality.
Teixeira MR; Heim S
Adv Cancer Res; 2011; 112():127-49. PubMed ID: 21925303
[TBL] [Abstract][Full Text] [Related]
29. Mutations, evolution and the central role of a self-defined fitness function in the initiation and progression of cancer.
Gatenby RA; Brown J
Biochim Biophys Acta Rev Cancer; 2017 Apr; 1867(2):162-166. PubMed ID: 28341421
[TBL] [Abstract][Full Text] [Related]
30. Somatic mutation and clonal expansions in human tissues.
Martincorena I
Genome Med; 2019 May; 11(1):35. PubMed ID: 31138277
[TBL] [Abstract][Full Text] [Related]
31. SigsPack, a package for cancer mutational signatures.
Schumann F; Blanc E; Messerschmidt C; Blankenstein T; Busse A; Beule D
BMC Bioinformatics; 2019 Sep; 20(1):450. PubMed ID: 31477009
[TBL] [Abstract][Full Text] [Related]
32. Clonality analysis in primary oral squamous cell carcinoma and related lymph-node metastasis revealed by TP53 and mitochondrial DNA next generation sequencing analysis.
Morandi L; Tarsitano A; Gissi D; Leonardi E; Balbi T; Marchetti C; Montebugnoli L; Foschini MP
J Craniomaxillofac Surg; 2015 Mar; 43(2):208-13. PubMed ID: 25530302
[TBL] [Abstract][Full Text] [Related]
33.
Weyerer V; Eckstein M; Strissel PL; Wullweber A; Lange F; Tögel L; Geppert CI; Sikic D; Taubert H; Wach S; Wullich B; Hartmann A; Stoehr R; Giedl J
Genes (Basel); 2021 Feb; 12(2):. PubMed ID: 33562516
[TBL] [Abstract][Full Text] [Related]
34. Studying tumorigenesis through network evolution and somatic mutational perturbations in the cancer interactome.
Cheng F; Jia P; Wang Q; Lin CC; Li WH; Zhao Z
Mol Biol Evol; 2014 Aug; 31(8):2156-69. PubMed ID: 24881052
[TBL] [Abstract][Full Text] [Related]
35. The natural somatic mutation frequency and human carcinogenesis.
Simpson AJ
Adv Cancer Res; 1997; 71():209-40. PubMed ID: 9111867
[TBL] [Abstract][Full Text] [Related]
36. Pan-cancer whole-genome analyses of metastatic solid tumours.
Priestley P; Baber J; Lolkema MP; Steeghs N; de Bruijn E; Shale C; Duyvesteyn K; Haidari S; van Hoeck A; Onstenk W; Roepman P; Voda M; Bloemendal HJ; Tjan-Heijnen VCG; van Herpen CML; Labots M; Witteveen PO; Smit EF; Sleijfer S; Voest EE; Cuppen E
Nature; 2019 Nov; 575(7781):210-216. PubMed ID: 31645765
[TBL] [Abstract][Full Text] [Related]
37. Clonality, Heterogeneity, and Evolution of Synchronous Bilateral Ovarian Cancer.
Yin X; Jing Y; Cai MC; Ma P; Zhang Y; Xu C; Zhang M; Di W; Zhuang G
Cancer Res; 2017 Dec; 77(23):6551-6561. PubMed ID: 28972072
[TBL] [Abstract][Full Text] [Related]
38. The mutational spectrum of squamous-cell carcinoma of the head and neck: targetable genetic events and clinical impact.
Mountzios G; Rampias T; Psyrri A
Ann Oncol; 2014 Oct; 25(10):1889-1900. PubMed ID: 24718888
[TBL] [Abstract][Full Text] [Related]
39. Mutational processes shape the landscape of TP53 mutations in human cancer.
Giacomelli AO; Yang X; Lintner RE; McFarland JM; Duby M; Kim J; Howard TP; Takeda DY; Ly SH; Kim E; Gannon HS; Hurhula B; Sharpe T; Goodale A; Fritchman B; Steelman S; Vazquez F; Tsherniak A; Aguirre AJ; Doench JG; Piccioni F; Roberts CWM; Meyerson M; Getz G; Johannessen CM; Root DE; Hahn WC
Nat Genet; 2018 Oct; 50(10):1381-1387. PubMed ID: 30224644
[TBL] [Abstract][Full Text] [Related]
40. Analysis of mutations in tumor and normal adjacent tissue via fluorescence detection.
Kay JE; Mirabal S; Briley WE; Kimoto T; Poutahidis T; Ragan T; So PT; Wadduwage DN; Erdman SE; Engelward BP
Environ Mol Mutagen; 2021 Feb; 62(2):108-123. PubMed ID: 33314311
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]